6 news items
Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
TAK
18 Jun 24
appropriate patient or caregiver training or administered by a healthcare professional in a medical office, infusion center or at a patient's home
Halozyme's ENHANZE Product Gets New Patent Grant in EU
ABBV
ABOS
ALXO
6 Jun 24
(OTC:ARGNF), ViiV Healthcare, Chugai Pharmaceutical
HEALWELL AI's Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema
TAK
6 Jun 24
highlights the transformative impact data science can have in healthcare. Together, we are breaking new ground in real-world evidence analysis
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
BX
TAK
3 Jun 24
the Japanese consumer healthcare firm Alinamin Pharmaceutical Co., previously owned by Takeda Pharmaceutical Company Limited
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
TAK
22 Apr 24
+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners
5jzwnmgor3s66e2 2ax
TAK
27 Mar 24
.
The 'In Their Shoes' initiative offers participants (Healthcare Professionals) a profound understanding of IBD throughout a 24
- Prev
- 1
- Next